Drug recall · January 25, 2023
Triamterene and Hydrochlorothiazide Capsules recall
Why: Failed Impurity/Degradation Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000 ] Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 100 Count bottle: 0527-1632-01; NDC 1,000 bottle: 0527-1632-10
- Lots / codes
Lots: 21000279A (exp 01/2023), 20256320A (12/2022)
- Quantity
- 20,040 bottles
- Company
- Lannett Company Inc., Seymour, IN
- Distribution
- Nationwide USA
- Initiated
- November 9, 2022 · Voluntary: Firm initiated
- Classified
- January 16, 2023
- Reported
- January 25, 2023
- Ended
- June 8, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.